AASLD

Leadership Positions

AASLD Committees, Special Interest Groups (SIGs), and Journal Editorial Boards 

Patricia Bloom, MD
Communications and Technology Committee, Member
Hepatology Communications, Associate Editor

Vincent Chen, MD, MS
Hepatology Communications, Editorial Board

Robert Fontana, MD, FAASLD
Hepatology, Editorial Board
Hepatology Communications, Editorial Board
Hepatotoxicity SIG, Member
Annual Program Committee, Member

Andrea Gajos, ANP-BC
Hepatology Associates Committee, Member

Anna Lok, MD, FAASLD
Hepatitis B SIG, Steering Committee
Hepatitis Elimination Taskforce, Member
Hepatology Communications, Associate Editor

Jessica Mellinger, MD, MSc
Practice Guidelines Committee, Member
Clinical Liver Disease, Associate Editor
Hepatology Communications, Editorial Board
Liver Transplantation, Editorial Board

Neehar Parikh, MD, MS
Practice Metrics Committee, Member
Hepatology,Editorial Board
Liver Transplantation, Editorial Board
Hepatology Communications, Associate Editors

Ponni Perumalswami, MD
Research Awards Committee, Member
Hepatology Communications, Editorial Board

Nataliya Razumilava, MD
Continuing Medical Education Committee, Member
Hepatology Editorial Board, Member

Pratima Sharma, MD, MS
Acute on Chronic Liver Failure SIG, Steering Committee
Annual Meeting Education Committee, Member
Liver Transplantation and Surgery SIG, Steering Committee
Liver Transplantation, Associate Editor
Hepatology, Editorial Board Member

Elizabeth Speliotes, MD, PhD, MPH, FAASLD
AASLD Ethics Committee, Member

Grace Su, MD, FAASLD
AASLD 2022 Governing Board, Councilor
AASLD 2022 Strategic Planning Committee, Co-Chair                            

Elliot Tapper, MD
Practice Metrics Committee, Chair
Cirrhosis Quality Collaborative, Steering Committee
Hepatology, Editorial Board
Hepatology Communications, Editor-In-Chief
Liver Transplantation, Editorial Board

Chairs and Moderators

Friday, November 4

Optimizing Pre- and Post-Transplant Management of Immune Mediated Liver Disease, PART 1
1:00 – 2:30 pm
Program Chair: Pratima Sharma, MD, MS

Optimizing Pre- and Post-Transplant Management of Immune Mediated Liver Disease, PART 2
3:30 – 5:00 pm
Program Chair: Pratima Sharma, MD, MS

4:40 – 5:00 pm
Case-discussion- Moderator: Pratima Sharma, MD, MS

Sunday, November 6

Meet The Experts 15: COVID-19 in Liver Patients; Treatment, and Vaccines        
8:00 - 8:45 AM
Moderator & Program Chair:Robert Fontana, MD, FAASLD

Covid-19 and the Liver Symposium
4:30-6:00 pm
Moderator: Robert Fontana, MD, FAASLD

Monday, November 7

Meet the Experts 16: Leveraging telehealth in liver disease
8:00 – 8:45 am
Moderator: Elliot Tapper, MD

Meet the Experts 19: Best Practices in Hepatology Telemedicine
1:15 – 2:00 pm
Moderator: Elliot Tapper, MD

Acute on Chronic Liver Failure
2:30 – 3:30 pm
Moderator: Pratima Sharma, MD, MS

Emerging Trends Symposium: Novel Care Models for ALD
4:30 – 6:00 pm
Moderator: Jessica Mellinger, MD, MSc

Invited Speakers

Thursday, November 3

AASLD Industry Colloquium: Perspectives and Advances in Liver Preservation
9:40 – 10:00 am
Organogenesis: Development of Liver Buds
Nataliya Razumilava, MD

Friday, November 4

Navigating HBV Treatment and Cure by Starting or Stopping Nucleos(t)ide Analogues (NUC)
10:00 – 11:30am
Selecting different NUC for special populations
Anna Lok, MD, FAASLD

State of the Art Management of ACLF-Part 1
10:00 – 10:30 am
Risk Factors for Poor Post-Transplant Outcomes in the Patient with ACLF
Pratima Sharma, MD, MS

Microbiota, Cirrhosis and Portal Hypertension
4:20 – 4:35 pm
Fecal Microbial Transplant for Cirrhosis and Portal Hypertension: Ready for Prime Time?
Patricia Bloom, MD

Saturday, November 5

Patient Engagement Forum – HBV/HDV
12:00-1:00 pm
Treat All or According to Guidelines – When to Start and When to Stop
Anna Lok, MD, FAASLD

Sunday, November 6

Meet-The Expert
8:00 – 8:45 am
Emerging Therapies for AUD
Jessica Mellinger, MD, MSc

Practice Guidelines Workshop: Highlights of Recently Finalized AASLD Practice Guidance’s
2:00 – 3:30 pm
Practice Guidance on Drug-Induced and Supplement-Induced Liver Disease
Robert J Fontana, MD, FAASLD

Postgraduate Course
4:30 – 4:50 pm
Therapies for Alcohol-Associated Hepatitis: Still a Mirage?
Jessica Mellinger, MD, MSc

Women's Leadership Program 
4:30 – 6:00 pm
Defining your leadership goals
Anna Lok, MD, FAASLD

Monday, November 7

Hepatitis Elimination Session
11:30 am – 1:00 pm
State Elimination Focus: New York and Michigan
Ponni Perumalswami, MD

Quality Measures in Coagulopathy: Multi-society Guidance
11:30 am – 1:00 pm
Practices in Quality Measures in Cirrhosis: What’s New in Recent Guidance Documents
Elliot Tapper, MD

Meet-The Expert
1:15 – 2:00 pm
Public Policy and Clinical Challenges in AUD and ALD
Jessica Mellinger, MD, MSc

Achieving Pharmacoequity in Liver Disease
2:00 – 3:30 pm
Advancing Health Equity in Research and Practice
Elliot Tapper, MD

Hepatitis B Endpoints Recap 
4:30 – 6:00 pm
Novel Treatment Endpoints and Biomarkers for HBV
Anna Lok, MD, FAASLD

Pre-Recoded
2022 Care Innovations in Hepatology - Implementation and Practical Applications for the Patient Journey in Hepatology
On-Demand

Innovations in Remote Hepatology Care: Before and After Liver Transplantation
Patricia Bloom, MD

 

Past AASLD Meetings

2021 AASLD

AASLD Foundation Advanced/Transplant Hepatology Award

Karn Wijarnpreecha, MD, MPH
Incidence of cirrhosis and extrahepatic manifestations in lean individuals with nonalcoholic fatty liver disease
Mentor: Anna S. Lok, MD, FAASLD

Leadership Positions

AASLD Committees, Special Interest Groups (SIGs), Journal Editorial Boards

Patricia P. Bloom, MD
Communications and Technology Committee

Trainee Member

Robert Fontana, MD, FAASLD
Hepatology
Editorial Board
Hepatology Communications
Editorial Board

Anna S. Lok, MD, FAASLD
Hepatitis B

Steering Committee
Hepatology
Editorial Board

Jessica L. Mellinger, MD, MSc
Practice Guidelines Committee

Member
Clinical Liver Disease
Associate Editor
Hepatology Communications
Editorial Board
Liver Transplantation
Editorial Board

Neehar D. Parikh, MD, MS
Practice Metrics Committee
Member
Liver Transplantation
Editorial Board

Nataliya Razumilava, MD
Continuing Medical Education Committee
Member

Pratima Sharma, MD, MS
Public Policy Committee
Member
Acute on Chronic Liver Failure
Steering Committee
Liver Transplantation and Surgery
Steering Committee
Liver Transplantation
Associate Editor

Grace L. Su, MD, FAASLD
AASLD 2021 Governing Board

Councilor
AASLD Executive Committee
Clinical Research Committee
Board Liaison
Continuing Medical Education Committee
Board Liaison
Maintenance of Certification Committee
Board Liaison
Membership and Mentorship Committee
Board Liaison

Elliott B. Tapper, MD
Practice Metrics Committee
Chair-Elect
Cirrhosis Quality Collaborative
Hepatology
Editorial Board
Hepatology Communications
Editorial Board
Liver Transplantation
Editorial Board

The Liver Meeting Program - Chairs, Moderators

Saturday, November 13, 2021

Parallel Session 4: COVID-19 Clinical
1:00 pm – 2:30 pm
Moderator: Robert Fontana, MD, FAASLD 

Sunday, November 14, 2021

Late Breaking Session 1
1:00 pm – 2:30 pm
Moderator: Grace L. Su, MD, FAASLD

COVID-19 and the Liver Symposium
7:00 pm – 8:30 pm
Program Chair: Robert Fontana, MD, FAASLD 

Monday, November 15, 2021

Parallel Session 30: Genomics and Precision Medicine
12:30 pm – 2:00 pm
Moderator: Vincent Chen, MD

Invited Speakers

Friday, November 12, 2021

Hepatitis B SIG

11:30 am – 1:00 pm

Novel biomarker – Advances in disease outcome and HBV cure prediction
Anna S. Lok, MD, FAASLD

Public Health / Health Care Delivery SIG

5:30 – 7:00 pm

Behavior management of alcohol-related liver disease (ALD
Jessica L. Mellinger, MD, MSc

Monday, November 15, 2021

Emerging Trends Symposium

10:00 – 11:30 am

NAFLD pathophysiological subtypes: Insights from human genetics
Elizabeth K. Speliotes, MD, PhD, MPH

Pre-event Sessions

Pre-event sessions will launch on Monday, November 8, 2021.

AASLD/ASGE Endoscopy Course

Clinical Challenges and Practical Solutions at the Interface of Liver Disease and Endoscopy

6:00 – 11:25 am

Allison Schulman, MD, MPH

General Hepatology Update

6:00 – 7:30 am

Title of talk TBD
Jessica L. Mellinger, MD, MSc

Value-based Medicine in Hepatology

6:00 – 7:30 am

Title of talk TBD
Elliot B. Tapper, MD

Friday, November 12, 2021

Career Development Workshop

3:00 – 4:30 pm

Elliot B Tapper, MD

AASLD 2021 Academic Debates

7:00 – 8:30 pm

Anuhya Gampa, Matthew Odenwald, Jasleen Singh, Sentia Iriana, Kara Wegermann, Jacqueline Henson, Jason Pan, Abhishek Shenoy

Sunday, November 14, 2021

Basic Research Workshop - Part I (From Liver Phenotype to Gene Discovery)

10:00 – 11:30 am

Elizabeth K. Speliotes, MD, PhD, MPH

Monday, November 15, 2021

Meet the Expert

9:00–10:00 am

Patricia P. Bloom, MD
The role of the microbiome in the pathophysiology of portal hypertension and its complications

Parallel Sessions - Oral Abstract Presentations

Saturday, November 13, 2021

Parallel Session 6: Experimental and Translational Portal Hypertension and ACLF
6:30 – 8:00 pm

Abstract #50
Clustered molecular responses to hyperammonemia mediate sarcopenia in cirrhosis with accelerated skeletal muscle senescence
Nicole Welch, Shashi Shekhar Singh, Avinash Kumar, Saugato Rahman Dhruba, Saurabh Mishra, Jinendiran Sekar, Annette Bellar, Amy Attaway, Aruna Kumar Chelluboyina, Belinda Willard, Ling Li, Zhiguang Huo, Sadashiva S. Karnik, Karyn Esser, Michelle Longworth, Yatrik Shah, Gangarao Davuluri, Ranadip Pal, Srinivasan Dasarathy

Parallel Session 8: HBV cascade of care, natural history and diagnostics
6.30–8.00 pm

Abstract #65
Role of HBV RNA and hepatitis B core-related antigen in predicting sustained inactive carrier phase in chronic hepatitis B
Marc G. Ghany, Wendy C. King, Anna S.F. Lok, Norah Terrault, Harry L.A. Janssen, Raymond T. Chung, Mauricio Lisker-Melman, Amanda S. Hinerman, Mandana Khalili, William M. Lee, Daryl T.Y. Lau, Gavin A. Cloherty, Richard K. Sterling, and the HBRN

Parallel Session 9: COVID-19 Translational and Clinical
6:30 – 8:00 pm

Abstract #71
Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter study cold study
Elizabeth Aby, Jenna L Gustafson, Michael Daidone, Raymond T Chung, Sunny Sandhu, Aalam Sohal, Sameeha Khalid, Marina Roytman, Lee Varelas, Akshata Moghe, Ghady Moafa, Nyan L Latt, Rotonya M Carr, Yedidya Saiman, Andreea M Catana, Ihab Kassab, Vincent Chen, Carly Rosenberg, Jose D. Debes, Atoosa Rabiee, Veronica Nguyen, Christina Gainey, Kali Zhou, Kenneth D. Chavin, Blanca Lizaola-Mayo, Sonal Kumar, Renumathy Dhanasekaran

Sunday, November 14, 2021

Parallel Session 11: Healthcare Quality and Access in Hepatology
10:00 – 11:30 am

Abstract #84
The SCAN-ECHO force multiplier effect builds primary care provider capacity through virtual consultations to improve survival for veterans living with liver disease
Ponni V. Perumalswami, Kyle Kumbier, Bradley Youles, Patrick Belancourt, Sameer Saini, Grace L. Su

Parallel Session 19: Clinical Advances in Alcohol-Associated Liver Disease
4:00 – 5:30 pm

Abstract #129
Polygenic risk scores improve identification of individuals at increased risk of alcohol-related liver disease, above alcohol intake alone
Kelly Cushing, Xiaomeng Du, Yanhua Chen, Lc Stetson, Annapurna Kuppa, Elizabeth K. Speliotes

Parallel Session 20: Hepatobiliary Neoplasia: Clinical Oral Session
4:00 – 5:30 pm

Abstract #138
GALAD score improves early detection of HCC prior to the diagnosis of HCC: A phase 3 biomarker validation study
Jorge A. Marrero, Tracey L Marsh, Neehar D. Parikh, Lewis R. Roberts, Myron E Schwartz, Mindie H. Nguyen, Alex Befeler, Stephanie Page-Lester, Jeffrey Winick, Mara Vecchio, Paul Wagner, Sudhir Srivastava, Jo Ann Rinaudo, Amit G. Singal, Ziding Feng, K Rajender Reddy

Monday, November 15, 2021

Parallel Session 27: Diversity, Equity, and Inclusion in Liver Disease Care
10:00 – 11:30 am

Abstract #179
Trends in the inpatient burden of alcohol related liver disease among women hospitalized in the United States
Madeline Bertha, Kerby Shedden, Jessica L. Mellinger

Parallel Session 30: Genomics and Precision Medicine
12:30 – 2:00 pm

Abstract #196
A blood-based prognostic liver secretome signature predictive of long-term HCC risk to guide chemopreventive intervention in advanced liver fibrosis
Naoto Fujiwara, Masahiro Kobayashi, Austin J Fobar, Cesia A Marquez, Bhuvaneswari Koneru, Tongqi Qian, Indu Raman, Quan-Zhen Li, Hitomi Sezaki, Hiromitsu Kumada, Ryosuke Tateishi, Takeshi Yokoo, Adam C Yopp, Raymond T Chung, Bryan C Fuchs, Thomas F. Baumert, Jorge A. Marrero, Neehar D. Parikh, Shijia Zhu, Amit G. Singal, Yujin Hoshida

2020 AASLD

AASLD Foundation Awards

Clinical, Translational and Outcomes Research Award

Vincent Chen, MD
Project Title: Integrating genetic and environmental factors to predict risk of non-alcoholic fatty liver disease
Mentor: Elizabeth K. Speliotes, MD, PhD, MPH

Pilot Research Award

Jun Wu, PhD
Project Title: A novel cholinergic circuitry in hepatic regulation
Mentor: Liangyou Rui, PhD

Leadership Positions

Councilor and AASLD President in 2025

We congratulate Grace Su, MD, FAASLD on her election as Councilor for the term 2021 – 2026. She will become the AASLD President in 2025.

AASLD and SIG Committees, Journal Editorial Boards

Patricia P. Bloom, MD
Communications and Technology Committee
Trainee Member

Robert J. Fontana, MD, FAASLD
Nominating Committee
Member (Elected)
Hepatology Communications
Editorial Board
Hepatology Communications
Editorial Board

Anna S. Lok, MD, FAASLD
Hepatitis B SIG
Steering Committee
Hepatology
Editorial Board

Jessica L. Mellinger, MD, MSc
Alcohol-associated Liver Disease SIG
Steering Committee
Clinical Liver Disease
Editorial Board
Hepatology Communications
Editorial Board

Pratima Sharma, MD, MS
Acute on Chronic Liver Failure SIG
Steering Committee
Liver Transplantation and Surgery SIG
Steering Committee
Public Policy Committee
Member
Liver Transplantation
Associate Editor

Elizabeth K. Speliotes, MD, PHD, MPH
Research Awards Committee
Member

Grace L. Su, MD, FAASLD
Annual Meeting Education Committee
Chair
Maintenance of Certification (MOC) Committee
Member
Scientific Program Committee
Member

Elliot B. Tapper, MD
Cirrhosis Quality Collaborative (CQC)
Steering Committee
Practice Metrics Committee
Chair-Elect
Public Health / Health Care Delivery SIG
Steering Committee
Hepatology
Editorial Board
Hepatology Communications
Editorial Board

Monica A. Tincopa, MD, MSc
Clinical Research Committee
Member

The Liver Meeting Program - Chairs, Moderators

Saturday, November 14, 2020

Emerging Trends Symposium
Artificial Intelligence (AI) in Hepatology
9:00 – 10:30 am
Co-chair: Grace L. Su

Parallel Session 2: Liver Transplantation: Immunosuppression/Outcomes/Complication
2:00 – 3:30 pm
Moderator: Pratima Sharma

Sunday, November 15, 2020

COVID-19 and the Liver Symposium
2:00 – 3:30 pm
Moderator: Robert J. Fontana 

Parallel Session 16: Hepatobiliary Neoplasia: Experimental and Novel Diagnostic/Imaging
5:30 – 7:00 pm
Moderator: Grace L. Su

Parallel Session 17: Hepatotoxicity
5:30 – 7:00 pm
Moderator: Robert J. Fontana

Monday, November 16, 2020

Parallel Session 20: Hepatobiliary Neoplasia: Clinical
9:00 – 10:30 am
Moderator: Neehar Parikh

Special Session

Conversation with our Nobel Laureates (2020 Nobel Laureates in Physiology and Medicine, Harvey Alter, MD, Michael Houghton, PhD, Charles Rice, PhD)
12:00-1:00 pm
Moderators: Jorge Bezerra, Raymond Chung, Anna Lok

Postgraduate Course

Saturday, November 14, 2020

Part 1. Paradigm Shifts in Hepatology: Rethinking Conventional Wisdom
8:00 am – 12:00 pm

In Session I Toward a biopsy-free world
Elliot B. Tapper

In Session V HBV and HDV: Can we now talk about cure?
Anna S. Lok

Oral Abstract Presentations

Saturday, November 14, 2020

Parallel Session: Hepatitis B: Therapeutics (Established)
9:00 – 10:30 am

9:00 am
Abstract #19
Randomized trial of 192 weeks of tenofovir with or without peginterferon alfa for the first 24 weeks followed by protocolized withdrawal in adults with chronic hepatitis B
Norah Terrault, Anna S Lok, Abdus Wahed, David KH Wong, Mandana Khalili, Michael W Fried, Daryl Lau, Marc G Ghany, Richard K Sterling, Adrian M Di Bisceglie, Robert P Perrillo, Mauricio Lisker-Melman, Stewart Cooper, Raymond T Chung, Keyur Patel, Lewis R Roberts, Charles Landis, Mohamed A Hassan, Christopher A Aoki, Steve Belle, Harry LA Janssen

Sunday, November 15, 2020

Presidential Plenary – Clinical and Outcomes Discoveries
9:00 – 10:30 am

AASLD Foundation Abstract Award
Abstract #9
Predictors of outcomes of COVID-19 in patients with chronic liver disease: US multi-center study
Nia Adeniji, Donghee Kim, Nyan L Latt, Sonal Kumar, Patricia P Bloom, Elizabeth S Aby, Ponni V. Perumalswami, Marina Roytman, Michael Li, Alexander S Vogel, Andreea M Catana, Kara Wegermann, Rotonya M Carr, Costica Aloman, Vincent Chen, Akshata Moghe, Veronica Nguyen, Brett Sadowski, Atoosa Rabiee, Winston Dunn, Kenneth D. Chavin, Kali Zhou, Blanca Lizaola-Mayo, Jose D Debes, Tzu-Hao Lee, Andrea D Branch, Kathleen Viveiros, Walter W Chan, David M Chascsa, Paul Y Kwo, Renumathy Dhanasekaran

Parallel Session 17: Hepatotoxicity
5:30 – 7:00 pm

Abstract #117
HLA risk alleles associated with drug induced liver injury due to antiepileptic drugs
Paola Nicoletti, Yi-Ju Li, Elizabeth J Phillips, Andrew Dellinger, Huiman Barnhart, Robert J Fontana, Herbert L Bonkovsky, Naga P Chalasani, and for the Drug Induced Liver Injury Network (DILIN)

Monday, November 16, 2020

Parallel Session 19: Acute/Acute on Chronic Liver Failure
9:00 am

Abstract #127
Prediction of survival in adults with ALF and non-acetaminophen ALI using the 13C methacetin breath test: Results of a prospective, multicenter trial
Robert J Fontana, R Todd Stravitz, Valerie L Durkalski-Mauldin, James Hanje, Bilal Hameed, David G Koch, Daniel R Ganger, Jody C Olson, Iris W Liou, Brendan M McGuire, Kristen Clasen, William M Lee

Parallel Session: Hepatitis B: Non-Therapy
10:30 am – 12:00 pm

Abstract #157
Do novel assays improve phenotypic characterization of adults with chronic hepatitis B?
Marc G Ghany, Wendy King, Mauricio Lisker-Melman, Gavin Cloherty, Mandana Khalili, Raymond T Chung, Norah Terrault, William M Lee, Daryl Lau, Harry LA Janssen, Anna S Lok, Richard K Sterling, and on behalf of the HBRN

Oral Session
Abstract #62
Association of serum biomarkers with liver stiffness assessed by transient elastography in 330 children with cholestatic liver disease
Daniel H Leung, Sridevi Devaraj, Nathan P Goodrich, Xinpu Chen, Deepthi B Rajapakshe, Wen Ye, Victor Andreev, Charles Minard, Danielle Guffey, Jean Pappas Molleston, Lee M Bass, Saul J Karpen, Binita M Kamath, Kasper S Wang, Shikha S Sundaram, Philip Rosenthal, Patrick James McKiernan, Kathleen M Loomes, M Kyle Jensen, Simon P Horslen, Jorge A Bezerra, John C Magee, Robert Merion, Ronald J Sokol, Benjamin L Shneider

Oral Session
Abstract #73
The relationship between physical frailty and impaired cognition in patients with cirrhosis
Kacey Berry, Andres Duarte-Rojo, Joshua D Grab, Michael A Dunn, Brian J Boyarsky, Betsy C Verna, Matthew R Kappus, Michael Volk, Mara McAdams-DeMarco, Dorry L Segev, Daniel R Ganger, Daniela P Ladner, Monica A Tincopa, Robert S Rahimi, Jennifer Cindy Lai

Oral Session
Abstract #339
Prognostic value of serum bile acids after achieving bile flow with the Kasai portoenterostomy in biliary atresia (formerly a poster abstract) okay to delete?
Sanjiv Harpavat, Kieran Hawthorne, Benjamin L Shneider, Lisa Henn, Charlotte Beil, Saul J Karpen, Vicky Lee Ng, Kenneth DR Setchell, Estella M Alonso, Jorge A Bezerra, Stephen L Guthery, Simon P Horslen, Binita M Kamath, Kathleen M. Loomes, Patrick James McKiernan, John C Magee, Robert M Merion, Jean Pappas Molleston, Philip Rosenthal, Richard J Thompson, Kasper S Wang, Ronald J Sokol, James E Heubi

Oral Session
Abstract #374
Multiomic integrated molecular landscape of hyperammonemia show a time-dependent change in chromatin accessibility and the translatome of sarcopenia of cirrhosis
Nicole M Welch, Avinash Kumar, Shashi S Singh, Saurabh Mishra, Jinendiran Sekar, Annette Bellar, Lin Ling, Dongmei Zhnag, Belinda Willard, Michelle Longworth, Yatrik Shah, Srinivasan Dasarathy

Posters

>>Acute/Acute on Chronic Liver Failure

Abstract #184
Bleeding, thrombosis, and outcome according to rotational thromboelastometry (ROTEM) parameters in patients with acute liver injury/failure
R Todd Stravitz, Robert J Fontana, Caitlyn Meinzer, Valerie L Durkalski-Mauldin, Adam James Hanje, Jody C Olson, David G Koch, Bilal Hameed, Michael L Schilsky, Brendan M McGuire, Daniel R Ganger, Iris W Liou, Constantine J Karvellas, Ton Lisman, Kristen Clasen, William M Lee, ALF Study Group

Abstract #186
CPS1 is a prognostic biomarker in patients with acute liver failure
Raymond Kwan, Min-Jung Park, Sujith VW Weerasinghe, Zemin Su, William M Lee, Valerie L Durkalski-Mauldin, Robert J Fontana, M Bishr Omary

AASLD Presidential Poster of Distinction
Abstract #203
Trends in severe acute idiosyncratic drug induced liver injury: An update from the ALFSG Registry
Ashwin Rao, Jody A Rule, Bilal Hameed, Daniel R Ganger, Robert J Fontana, William M Lee

>>Alcohol Associated Liver Disease: Clinical and Experimental

Abstract #276
Provider attitudes and practices for alcohol screening, treatment and education in patients with liver disease
Jessica L Mellinger, Gene Y Im, Adam Winters, Elizabeth S Aby, Zurabi Lominadze, Michael R Lucey, John P Rice, Loretta Jophlin, Juan Pablo Arab, Aparna Goel, Courtney Sherman, Deepika Devuni, Richard Parker, Po-Hung Chen, Sandeep Sidhu, Winston Dunn, Gyongyi Szabo, Ashwani K Singal, Vijay Shah

>>COVID-19 and the Liver

Abstract #430
COVID-19 outcomes among solid organ transplant recipients: a matched case-control study
Pratima Sharma, Vincent Chen, Christopher M Fung, Jonathan P Troost, Vaiibhav N Patel, Michael Combs, Silas P Norman, Puneet Garg, Monica Colvin, Keith Aaronson, Christopher J Sonnenday, Jonathan Golob, Emily C Somers, Mona M Doshi

Abstract #438
Hepatic steatosis is associated with elevated alanine aminotransferase (ALT) but not elevated bilirubin or hepatic decompensation in patients with novel coronavirus disease 2019 (COVID-19)
Ihab A Kassab, Fadi Hawa, Jeffrey A Berinstein, Calen A Steiner, Kevin D Platt, Jeremy Louissaint, Chia-Yang Hsu, Chanakyaram A Reddy, Naresh T Gunaratnam, Vincent Chen, Pratima Sharma

Abstract #439
Hepatic steatosis is associated with increased disease severity in patients with novel coronavirus 2019 (COVID-19)
Fadi Hawa, Ihab A Kassab, Jeffrey A Berinstein, Calen A Steiner, Kevin D Platt, Jeremy Louissaint, Chia-Yang Hsu, Chanakyaram A Reddy, Naresh T. Gunaratnam, Vincent Chen, Pratima Sharma

Abstract #471
Patterns and predictors of liver injury in liver transplant recipients with coronavirus disease 2019 (COVID-19)
Atoosa Rabiee, Brett Sadowski, Nia Adeniji, Veronica Nguyen, Akshata Moghe, Ponni V Perumalswami, Nyan L Latt, Sonal Kumar, Costica Aloman, Maria-Andreea Catana, Patricia P Bloom, Kenneth D Chavin, Rotonya M Carr, Winston Dunn, Vincent Chen, Elizabeth S Aby, Jose D Debes, Renumathy Dhanasekaran, COLD Consortium

>>Genomics and Precision Medicine

Abstract #606
Polygenic risk scores for transaminases are associated with hepatic steatosis and cirrhosis
Vincent Chen, Xiaomeng Du, Yanhua Chen, LC Stetson, Elizabeth K Speliotes

>>Cirrhosis

Abstract #627
A telemonitoring system is feasible for outpatient cirrhotic ascites management
Patricia P Bloom, Zoe Reinus, Jessica Shay, Jasmine Ha, James M Richter

>>Health Services Research: Patient Centered Outcomes Research

Abstract #703
Cost-effectiveness of alcohol cessation interventions among patients with alcohol-related cirrhosis
Anton Avencena, Nicholas Miller, Sarah Uttal, David Hutton, Jessica L Mellinger

>>Hepatitis B: Epidemiology, Prevention, Natural History

Abstract #773
Symptoms of chronic liver disease are associated with higher risk of adverse clinical outcomes: A longitudinal study in a large cohort of North American adults with chronic hepatitis B
Donna M Evon, Hsing-Hua Lin, Robert J Fontana, Mandana Khalili, Colina K Yim, Abdus Wahed, Jay H Hoofnagle, Hepatitis B Research Network (HBRN) 

>>Hepatobiliary Neoplasia: Clinical

AASLD Presidential Poster of Distinction
Abstract #1057
Incidence and predictive factors of hepatocellular carcinoma (HCC) in a prospectively followed US cohort of patients at risk: Hepatocellular carcinoma early detection strategy (HEDS) study
K Rajender Reddy, Neehar D Parikh, Lewis R Roberts, Myron E Schwartz, Mindie H Nguyen, Alex Befeler, Stephanie Page-Lester, Dale McLerran, Sudhir Srivastava, Jo Ann Rinaudo, Ziding Feng, Jorge A Marrero 

>>Hepatotoxicity: Pathogenesis and Mechanisms; Drug Metabolism, Toxicity, and Therapeutics; Predictors of Drug Toxicity

Abstract #1181
A revised electronic version of RUCAM for the diagnosis of drug induced liver injury
Paul H Hayashi, M Isabel Lucena, Robert J Fontana, Einar Bjornsson, Guruprasad P Aithal, Huiman Barnhart, A Gonzalez-Jimenez, Qinghong Yang, Jiezhun Gu, Raul J Andrade, Jay H Hoofnagle, DILIN Investigators

Abstract #1185
Checkpoint inhibitor hepatotoxicity is characterized by peripheral eosinophilia and hepatocellular or mixed injury at onset but a low risk of liver failure during follow-up
Robert J Fontana

Abstract #1194
Identifying cases of idiosyncratic drug-induced liver injury using ICD-10 codes for drug toxicity/poisoning and liver failure
Jeremy Louissaint, Ihab A Kassab, Amoah Yeboah-Korang, Robert J Fontana

>>Liver Transplantation

Abstract #1317
Automated measurements of body composition in abdominal CT scans using deep learning can predict survival in patients with cirrhosis
Winnie Zou, Binu Enchakalody, Nidhi Shah, Peng Zhang, Grace L Su

Abstract #1342
Factors associated with cardiovascular events after simultaneous liver kidney transplant (SLKT): Results from the U.S. multicenter SLKT Consortium
Jennifer Jo, Dyanna Gregory, Jasmine Sinha, Jiaheng Xie, Min ZhangJohn C Magee, Pranab M. Barman, Yuval Patel, Aaron Schluger, Kara Walter, Scott W Biggins, Giuseppe Cullaro, Randi Wong, Jennifer Cindy Lai, Elizabeth C Verna, Pratima Sharma, Lisa B VanWagner

Abstract #1389
Predictors of length of stay and death for simultaneous liver–kidney transplant (SLKT) index admission: Results from the US multicenter SLKT Consortium
Pranab M Barman, Jiaheng Xie, Min Zhang, Jennifer Jo, Jasmine Sinha, Aaron Schluger, Kara Walter, Scott W Biggins, Giuseppe Cullaro, Randi Wong, Jennifer Cindy Lai, Lisa B. VanWagner, John C Magee, Betsy C Verna, Yuval Patel, Pratima Sharma

Abstract #1402
Risks of early hospitalization after simultaneous liver and kidney transplant (SLKT): Analysis from the United States (US) multicenter SLKT Consortium
Pratima SharmaJiaheng Xie, Min Zhang, Pranab M Barman, John C Magee, Jennifer Jo, Jasmine Sinha, Aaron Schluger, Kara Walter, Giuseppe Cullaro, Randi Wong, Scott W Biggins, Jennifer Cindy Lai, Lisa B VanWagner, Betsy C Verna, Yuval Patel

Abstract #1419
The relationship between frailty and etiology of cirrhosis: from the multi-center functional assessment in liver transplantation (FRAILT) study
Chelsea Xu, Yara Mohamad, Matthew R Kappus, Brian J Boyarsky, Daniel R Ganger, Michael Volk, Robert S Rahimi, Andres Duarte-Rojo, Mara McAdams-DeMarco, Dorry L Segev, Daniela P Ladner, Betsy C Verna, Monica A Tincopa, Michael A Dunn, Jennifer Cindy Lai

>>Liver Disease and Cystic Fibrosis

Abstract #1457
Characteristics and clinical liver disease in children with sonographic nodular liver (sonic) in cystic fibrosis
Jean Pappas Molleston, Wen Ye, Sarah Jane Schwarzenberg, Alvin J Freeman, Joseph Palermo, Alexander Weymann, Estella M Alonso, Wikrom Karnsakul, Karen F Murray, John C Magee, Daniel H Leung, Michael R Narkewicz,

>>Nonalcoholic Fatty Liver Disease

Abstract #1565
A pragmatic clinical prognostic classification suitable for universal application stratifies patients with NAFLD by risk of mortality and both hepatic and extrahepatic outcomes
Arun J Sanyal, Meng Wang, Kenneth Cusi, Alfred Sidney Barritt IV, Mark Dhinesh Muthiah, Stephanie Watkins, K Rajender Reddy, Roberto J Firpi, Paul J. Thuluvath, Kalyan Ram Bhamidimarri, Anna S Lok, Michael W Fried 

Abstract #1569
Association of nonalcoholic fatty liver disease with cognition and brain volumes in the ACCORD randomized clinical trial
Neal Parikh
, Cenai Zhang, Russell Rosenblatt, Sonal Kumar, Elliot B Tapper, Hooman Kamel, Costantino Iadecola

>>Nonalcoholic Steatohepatitis

Abstract #1574
Burden of stage 2/3 fibrosis associated with nonalcoholic steatohepatitis: A cost of illness analysis
Darshini Shah, Elliot B Tapper, Kate Burslem, Steve Marcus, Jalpa A Doshi 

Abstract #1595
Heterogeneous documentation and poor concordance of NASH pathology may limit its clinical utility in real-world practice
Hannah Kim, Michael O Idowu, Richard C. Zink, Andrea Mospan, Michael Roden, Philip N Newsome, Anna S Lok, Paul J Thuluvath, Jawahar L Taunk, Michael W Fried, Arun J Sanyal, Alfred Sidney Barritt IV

>>Other Portal Hypertension Complications

Abstract #1743
Comparison of seven noninvasive models for predicting decompensation and hospitalization in patients with cirrhosis
Chia-Yang Hsu, Teh-Ia Huo, Neehar D. Parikh, Elliot B Tapper

AASLD Presidential Poster of Distinction
Abstract #1758
Hepatic encephalopathy is associated with a distinct speech pattern
Patricia P Bloom, Ashwini Arvind, Michael Daidone, Jessica Robin, Mengdan Xu, Anoopum S Gupta, Raymond T Chung

Abstract #1769
Noninvasive liver indices predict early decompensation in patients with newly diagnosed cirrhosis
Chia-Yang Hsu, Neehar D Parikh, Elliot B Tapper, Teh-Ia Huo

Abstract #1771
Nonselective beta-blocker use as an independent predictor of total number of hepatic encephalopathy-related admissions in patients with cirrhosis
Mohammad Amin Fallahzadeh, Sumeet K Asrani, Elliot B Tapper, Giovanna Saracino, Daniel Bizzarri, Robert S Rahimi

Abstract #1776
Prophylaxis and treatment of hepatic encephalopathy improves health-related quality of life, sleep, and social functioning
Andrew Moon, Hannah Kim, Jennifer S Walker, Charles Poole, Alfred Sidney Barritt IV, Elliot B Tapper

Abstract #1826
Morbidity and mortality following emergent or non-emergent umbilical hernia surgery in a national sample of US veterans with or without cirrhosis
Kay Johnson, Kira Newman, Kristin Berry, Pamela Green, Peter C Wu, Paul B Cornia, Lauren A. Beste, Kamal Itani, Alex HS Harris, Patrick S Kamath, George Ioannou

2019 AASLD

Awards

Vincent Chen, MD, MS
Clinical Lecturer
Early Career Investigator Award in Clinical/Translational Science

Mary Thomson, MD
Advanced Transplant Hepatology Fellow
Advanced/Transplant Hepatology Award

Leadership Positions

Hari Conjeevaram, MD, MS – Professor
Training and Workforce Committee

Robert Fontana, MD – Professor
Clinical Research Committee
AASLD Nominating Committee
Hepatology, Editorial Board
Hepatology Communications, Editorial Board

Anna Lok, MD – Professor
Global Outreach and Engagement Committee, Global Advisory Council Chair
Hepatology, Editorial Board

John C. Magee, MD – Professor
Scientific Program Committee
Surgery and Liver Transplantation Committee, Chair

Jessica Mellinger, MD, MS – Assistant Professor
Hepatology Communications, Editorial Board
Clinical Liver Diseases, Editorial Board

Neehar Parikh, MD, MS – Assistant Professor
Practice Metrics Committee

Pratima Sharma, MD, MS – Associate Professor
Publications Committee
Public Policy Committee
Liver Transplantation, Associate Editor

Grace Su, MD – Professor
Annual Meeting Education Committee, Chair
Scientific Program Committee
Maintenance of Certification (MOC) Committee

Andrew Tai, MD, PhD – Associate Professor
Research Awards Committee

Elliot Tapper, MD – Assistant Professor
Practice Metrics Committee, Vice Chair
Hepatology Communications, Editorial Board
Hepatology, Editorial Board

The Liver Meeting Program - Moderators, Chairs

Sunday, November 10, 2019

Parallel 2: Hepatitis C: Long-Term Outcomes and Unique Populations
CC, Room 304/306
8:30-10:00 am
Moderators: Grace L. Su, Raymond Chung

Parallel 11: Liver Transplant: Renal and Metabolic Issues
CC, Room 304/306
2:00-3:30 pm
Moderators: Pratima Sharma, Glen Lutchman

Parallel 14: HCC Translational and Biomarkers
CC, Ballroom BC
4:30-6:00 pm
Moderators: Denise Harnois, Neehar D. Parikh

#LiverTwitter: An Emerging Tool for Liver Education and Research
CC, Room 312
2:00-3:30 pm
Chairs: Elliot B. Tapper, Rohit S. Satoskar

Postgraduate Course

Saturday, November 9, 2019

Session I – Precision Medicine in 2019
CC Auditorium
8:45–9:05 am
Precision medicine and patients at risk for drug-induced liver injury
Robert Fontana

Workshops, Courses, President's Choice Lecture, Global Forum

Friday, November 8, 2019

Career Development Workshop
CC, Room 311
2:20 pm
How to be a good mentee and identify mentors/sponsors to launch your career
Elliot B. Tapper

2:50 pm
How I make time for myself and my work
Monica Tincopa

Saturday, Nov 9, 2019

Meet-the-Professor Luncheon (MTP) 1
12:00 pm
Ask the expert on cirrhosis: What are the best strategies to avoid readmissions?
Elliot B. Tapper, Fasiha Kanwal

Transplant Surgery Workshop
CC, Room 304/306
2:50 pm
Case Presentation Stimulated Panel Discussion/Q&A
Monica Tincopa

Sunday, Nov 10, 2019

Diversity Workshop
CC, Room 311
10:35 am
Creating solutions for racial and ethnic disparities in health
John Carethers

Hepatology Associates Course
Sheraton, Constitution Ballroom
11:25 am
Hepatitis B update
Anna S. Lok

#LiverTwitter: An Emerging Tool for Liver Education and Research
CC, Room 312
2:05 pm
Setting up your Twitter, sending your first Tweet
Elliot B. Tapper

2:25 pm
Running a divisional Twitter account
Neehar Parikh

Value-Based Medicine in Hepatology
Sheraton, Republic Ballroom
3:25 pm
Telehealth for high-value liver care
Grace L. Su

President's Choice Lecture
CC, Auditorium
4:00 pm
Global Health
Tadataka Yamada

Monday, November 11, 2019

Early Morning Workshop - EMW–43
6:45 – 7:45 am
Quality and safety for hospitalized patients with cirrhosis
Elliot B. Tapper

Global Forum – Alcohol-Related Liver Disease (ALD)
CC, Room 312
3:20 PM
AASLD/U.S. Perspective
Jessica Mellinger

Abstracts – Oral Presentations

Sunday, November 10, 2019

Parallel 5: Health Service Research: Patient Centered Outcomes
CC, Room 312
10:30 am
0055
Patients with decompensated cirrhosis are not receiving the medications they need while receiving medications they do not need
Mary Thomson, Anna S. Lok, Elliot B. Tapper

11:45 am
0060
A prospective study to define the contemporary health state utilities for persons with cirrhosis
Chelsey Foster, Samantha Nikirk, Jad Baki, Neehar D. Parikh, Elliot B. Tapper        

Parallel 11: Liver Transplant: Renal and Metabolic Issues
CC, Room 304/306
3:15 pm
0096
Muscle mass measurements can be automated using deep learning
Nicholas Wang, Stewart Wang, Grace L. Su

Parallel 16: Health Services Research: Healthcare Delivery and Access
Sheraton, Republic Ballroom
4:30 pm
0121
Gastroenterology consultation improves mortality and healthcare utilization after hepatic encephalopathy: The first population-based outcomes study of Americans with cirrhosis
Elliot B. Tapper, Devin Aberasturi

5:00 pm
0123
Inpatient access to specialty care for cirrhosis-related admissions and its impact on length of stay, mortality, and 30-day readmissions in two large national cohorts
Marina Serper, David E. Kaplan, Tamar H Taddei, Elliot B. Tapper

Monday, November 11, 2019

Parallel 22: HBV Epidemiology Prevention
CC, Ballroom A
9:45 am
0162
Hepatic fat and steatohepatitis in a large multiethnic North American cohort of adults and children with chronic hepatitis B
Mandana Khalili, David Kleiner, Wendy King, Richard K. Sterling, Marc G. Ghany, Raymond T. Chung, Philip Rosenthal, Lisker-Melman, Rageshree Ramachandran, Ahul Bhan, Anna S. Lok

Parallel 29: HCC Treatment: Medical Approaches
CC, Ballroom BC
10:30
0199
Direct-acting antiviral therapy is associated with improved survival in patients with a history of hepatocellular carcinoma: A multicenter North American cohort study
Amit G. Singal, Nicole E. Rich, Neil Mehta, Andrea D. Branch, Anjana A. Pillai, Maarouf A. Hoteit, Michael Volk, Mobolaji Odewole, Steven J. Scaglione, Jennifer E. Guy, Adnan Said, Jordan J. Feld, Binu John, Catherine T. Frenette, Parvez S. Mantry, Amol S. Rangnekar, Omobonike Oloruntoba, Michael D Leise, Janice Jou, Kalyan Ram Bhamidimarri, Laura M. Kulik, George Ioannou, Annsa Huang, Tram T. Tran, Hrishikesh V. Samant, Renumathy Dhanasekaran, Andres Duarte-Rojo, Reena J. Salgia, Sheila L. Eswaran, Prasun K. Jalal, Avegail Flores, Sanjaya Kumar Satapathy, Neehar D. Parikh, Caitlin Murphy

11:00 am
0201
Financial burden is common in U.S. patients with cirrhosis and associated with lower HCC surveillance receipt
Amit G. Singal, Katharine McCallister, Cynthia Ortiz, Jennifer Kramer, Song Zhang, Aisha Khan, Yan Liu, Nicole E. Rich, Neehar D. Parikh, Jasmin Tiro, Purva Gopal, Simon Lee, Caitlin Murphy, Ruben Hernaez

Parallel 31: Hepatotoxicity
CC, Room 302
10:30 am
0211
Discovery of ERAP2 gene expression as a risk factor for drug-induced liver injury due to amoxicillin–clavulanic acid
Paola Nicoletti, Federico Innocenti, Amy Etheridge, Naga P. Chalasani, Robert J. Fontana, Yi-Ju Li, Joseph Odin, Jose Serrano, Andrew Stolz, Guruprasad Aithal, Ann K. Daly, Paul B. Watkins, DILIN Investigators

10:45 am
0212
Increasing episodes of hepatotoxicity in the Drug-Induced Liver Injury Network associated with kratom, a botanical product with opioid-like activity
Victor J. Navarro, Joseph Odin, Jawad Ahmad, Paul H. Hayashi, Robert J. Fontana, Hari S. Conjeevaram, Bharathi Avula, Ikhlas Khan, Huiman Barnhart

Parallel 35: NAFLD and NASH: Epidemiology and Outcomes
Sheraton, Constitution Ballroom
3:15 pm
0240
Incidence of achieving weight loss goals in usual clinical practice: results for the TARGET-NASH observational cohort
Miguel H. Malespin, Alfred Sidney Barritt IV, Stephanie Watkins, Cheryl Schoen, Monica A. Konerman, Karen Corbin, Huy N. Trinh, L Michael Weiss, K Rajender Reddy, Rohit Loomba, Nyingi Kemmer, Anna S. Lok

Parallel Session: Late-Breaking Abstracts Oral Session I
CC, Auditorium
3.30 PM
LO5
The CONFIRM Study: A North American randomized controlled trial (RCT) of terlipressin plus albumin for the treatment of hepatorenal syndrome type 1 (HRS-1)
Florence Wong, Michael P Curry, K. Rajender Reddy, Raymond A Rubin, Michael K Porayko, Stevan Gonzales, Khalid Mumtaz, Nicholas Lim, Douglas Simonetto, Pratima Sharma, Arun Sanyal, Marlyn Mayo, Todd Frederick, S. Chris Pappas, Khurram Jamil on behalf of the CONFIRM Study Investigators

Abstracts – Poster Presentations

Friday, November 8, 2019

0318
Prognostic nutritional index is associated with improved survival in patients with hepatocellular carcinoma

Nicole E. Rich, Aarthi Parvathaneni, Adam C Yopp, Ahana Sen, Mobolaji Odewole, Ju Dong Yang, Yujin Hoshida, Neehar D. Parikh, Jorge A. Marrero, Amit G. Singal

0320
Prospective evaluation of benefits and harms of HCC surveillance in a cirrhosis patient population

Sruthi Patibandla, Joseph Obi Jr., Hannah Fullington, Katharine McCallister, Nicole E. Rich, Neehar D. Parikh, Purva Gopal, Jorge A. Marrero, Amit G. Singal

0322
Comparison of characteristics and prognosis of U.S. – Japan hepatocellular carcinoma patients detected under surveillance
Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Atsushi Hiraoka, Neehar D. Parikh, Amit G. Singal

0335
Multicenter cohort study of thermal ablation versus stereotactic body radiation therapy for hepatocellular carcinoma
Andrew Moon, Dawn Owen, Hannah Kim, Emily Sanders, Christian Beyer, Katrina A McGinty, Lauren M Burke, Paul H. Hayashi, Joel E Tepper, Paula D Strassle, Theodore S Lawrence, Charles S Mayo, Mishal Mendiratta-Lala, Neehar D. Parikh, Amit G. Singal, Karyn A Goodman, Marina Moskalenko, Daniel R Simpson, John Do, Yuko Kono, Steven C Rose, Jona A Hattangadi-Gluth, David A. Gerber, Kyle Wang

0369
Transarterial chemoembolization versus transarterial radioembolization for patients with hepatocellular carcinoma: a meta-analysis
Andrew Brown, Ihab A Kassab, Vincent L Chen, Whitney A Townsend, Amit G. Singal, Neehar D. Parikh

0390
Cost effectiveness of hepatocellular carcinoma surveillance: An assessment of benefits and harms
Neehar D. Parikh, Amit G. Singal, David Hutton, Elliot B. Tapper

0407
Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of privately-insured patients with compensated cirrhosis
Andrew Moon, Yue Jiang, Shari S Rogal, Elliot B. Tapper, Sarah Rosanna Lieber, Alfred Sidney Barritt IV

0491
Effectiveness of tenofovir alafenamide in patients with chronic hepatitis B treated in usual clinical practice: Results from the TARGET-HBV observational cohort study
David Eric Bernstein, Huy N. Trinh, Eugene R. Schiff, Coleman I Smith, Richard Zink, Anna S. Lok

0615
Diagnostic and treatment delays are common in patients with hepatocellular carcinoma

Ashwin Rao, Amit G. Singal, Neehar D. Parikh, Nicole E. Rich

0618
The impact of socioeconomic status on cirrhosis and hepatocellular carcinoma in the United States
Roselyn Nsenga, Sophia Tzavaras, Daniel Waldo, Amit G. Singal, Elliot B. Tapper, Neehar D. Parikh

0724
Patient knowledge deficits are associated with lower HCC surveillance receipt
Amit G. Singal, Katharine McCallister, Cynthia Ortiz, Jennifer Kramer, Song Zhang, Yan Liu, Aisha Khan, Nicole E. Rich, Jasmin Tiro, Neehar D. Parikh, Simon Lee, Caitlin Murphy, Ruben Hernaez

0727
Significant depression and anxiety are common in U.S. patients with cirrhosis
Amit G. Singal, Nicole E. Rich, Katharine McCallister, Cynthia Ortiz, Aisha Khan, Jennifer Kramer, Song Zhang, Elliot B. Tapper, Neehar D. Parikh, Jasmin Tiro, Simon Lee, Caitlin Murphy, Ruben Hernaez

0737
Patient-reported outcomes associated with chronic hepatitis B viral (HBV) infection in a large North American cohort: A cross-sectional analysis
Donna M. Evon, Hsing-Hua Lin, Mandana Khalili, Robert J. Fontana, Colina K. Yim, Abdus Wahed, Michael W Fried, Jay H. Hoofnagle, Hepatitis B Research Network (HBRN)

Saturday, November 9, 2019

0828
A prospective study of hepatitis E virus infection in North American patients with severe acute liver injury

Robert J. Fontana, Ronald E Engle, Michelle Gottfried, Hanje James, Bilal Hameed, Valerie L Durkalski-Mauldin, William M Lee, Patrizia Farci

0833
Does acute hepatitis C virus (HCV) infection ever lead to acute liver failure?
Jody A. Rule, Giuliana Cerro, R. Todd Stravitz, Brendan Martin McGuire, Robert J. Fontana, Dr. Jorge L. Rakela, William M Lee

0842
Growth rates of untreated hepatocellular carcinoma in patients with cirrhosis: A multicenter cohort study

Nicole E. Rich, Binu John, Neehar D. Parikh, Ian Rowe, Neil Mehta, Gaurav Khatri, Smitha Thomas, Munazza Anis, Mishal Mendiratta-Lala, Christopher Hernandez, Mobolaji Odewole, Latha T. Sundaram, Venkata R Konjeti, Shishir Shetty, Tahir Shah, Hao Zhu, Adam C Yopp, Yujin Hoshida, Jorge A. Marrero, Amit G. Singal

0881
No association between hepatocellular carcinoma surveillance and survival among patients with cirrhosis in the Optum database
Vincent L Chen, Elliot B. Tapper, Amit G. Singal, Neehar D. Parikh

0948
Low incidence of clinical outcomes in patients with chronic HBV infection in the era of nucleos(t)ide analogue (NA) therapy: Report from the Hepatitis B Research Network (HBRN) Adult Cohort Study
Anna S. Lok, Harry L. A. Janssen, Christina Lalama, Michael W Fried, Steve Belle, Robert P Perrillo, Dr. Marc G. Ghany, Mandana Khalili, Hepatitis B Research Network (HBRN)

0959
Incidence of HBsAg loss and HBeAg seroreversion among adults and children with HBeAg-negative chronic hepatitis B: Prospective analysis of a multi-ethnic North American cohort
Norah Terrault, Junyao Wang, Marc G. Ghany, Jordan J. Feld, Mandana Khalili, Philip Rosenthal, Robert J. Fontana, Mauricio Lisker-Melman, Richard K. Sterling, Raymond T. Chung, Harry L. A. Janssen

1131
The proportion of marijuana users among adult liver transplant candidates is increasing over time
Alisa Likhitsup, Gerald Winder, Ammar Hassan, Naba Saeed, Christopher J. Sonnenday, Robert J. Fontana

Sunday, November 10, 2019

1372
Bariatric surgery is associated with increased risk of alcohol-related cirrhosis and alcohol misuse
Jessica L. Mellinger, Kerby Shedden, Gerald Winder, Anne Fernandez, Brian Lee, Jennifer Waljee, Robert J. Fontana, Michael Volk, Frederic C Blow, Anna S. Lok

1738
Routinely available noninvasive tests perform well in identifying patients with advanced fibrosis due to NASH: Data from the TARGET-NASH observational cohort
Alfred Sidney Barritt IV, Anna S. Lok, K Rajender Reddy, L Michael Weiss, Roberto J. Firpi, Paul J. Thuluvath, Huy N. Trinh, Stephen Djedjos, Richard Haubrich, Andrew Billin, Bruce Koch II, Richard Zink, Arun J Sanyal, Kenneth Cusi, Brent A Neuschwander-Tetri

Monday, November 11, 2019

1855
Dependence of extrahepatic cholangiocyte proliferation on WNT signaling in in vivo murine and in vitro organoid co-culture models
Junya Shiota, Nureen Hanisah Mohamad Zaki, Linda Samuelson, Nataliya Razumilava

1892
Genome-wide association study of alanine transaminase and aspartate transaminase identifies diverse disease pathologies and effects on metabolic traits
Vincent L Chen, Xiaomeng Du, Yanhua Chen, Samuel Handelman, Elizabeth K. Speliotes

1905
Genetic variants that associate with liver cirrhosis have pleiotropic effects on human traits
Vincent L Chen, Yanhua Chen, Xiaomeng Du, Samuel Handelman, Elizabeth K. Speliotes

1906
Genome-wide association study for serum alkaline phosphatase identifies novel associations that affect liver and metabolic disease
Vincent L Chen, Xiaomeng Du, Yanhua Chen, Samuel Handelman, Elizabeth K. Speliotes

1910
GWAS of alcohol consumption in the UK biobank identifies variants that associate with metabolic and tissue-specific alcohol disease
Daniel Seung Kim, Xiaomeng Du, Yanhua Chen, Yatong K Li, Samuel Handelman, Jessica L. Mellinger, Elizabeth K. Speliotes

1911
Genetic variation in genes in the FXR/RXR pathways underlies effects on serum lipids and NAFLD
Samuel Handelman, Xiaomeng Du, Yanhua Chen, Elizabeth K. Speliotes

2036
A fucosylated kininogen-based biomarker panel is highly accurate for early detection hepatocellular carcinoma in patients with cirrhosis: A phase III biomarker evaluation
Anand Mehta, Mengjun Wang, Neehar D. Parikh, Nabihah Tayob, Jorge A. Marrero, Amit G. Singal

2044
Validation of GALAD for early detection of hepatocellular carcinoma in patients with cirrhosis
Neehar D. Parikh, Nabihah Tayob, Joy Lau, Cristian Saenz De Viteri, Jorge A. Marrero, Amit G. Singal

2232
Sex-specific reduction in liver damage and fat accumulation in a murine model of Lyplal1 KO
Rishel Vohnoutka, Yash Hegde, Yue Chen, Brian D. Halligan, Elizabeth K. Speliotes

2344
Upregulation of hedgehog signaling and inflammatory cytokines in the injury-induced proliferative response of extrahepatic bile duct cells
Nureen Hanisah Mohamad Zaki, Junya Shiota, Linda Samuelson, Nataliya Razumilava